Watson launches generic of ViroPharma's antibiotic

Tue Apr 10, 2012 6:15pm IST

Related Topics

(Reuters) - Generic drugmaker Watson Pharmaceuticals Inc said U.S. health regulators approved its copycat version of ViroPharma Inc's antibiotic Vancocin.

Separately, ViroPharma said the U.S. Food and Drug Administration declined its citizen petition, which was filed to prevent Watson from launching the generic version.

Shares of ViroPharma were trading down 18 percent at $23.40 in premarket.

Watson said it has started shipping the drug, which recorded sales of $332 million for the 12 months ended February 29, 2012.

ViroPharma shares closed at $28.61 on Monday on the Nasdaq.

(Reporting by Anand Basu in Bangalore; Editing by Sriraj Kalluvila)

FILED UNDER:

Ebola Watch

Feature: Africa's medicine men key to halting Ebola spread in Guinea

Feature: Africa's medicine men key to halting Ebola spread in Guinea

In a land where witchcraft is sought after more than science for curing illness, medicine men in Guinea say the Ebola epidemic would be over by now if they had been properly included in the outbreak response.  Full Article 

Reuters Showcase

Indian Healthcare

Indian Healthcare

Exclusive - Payment delays dent India's flagship health, AIDS programmes  Full Article 

India-Pakistan Ties

India-Pakistan Ties

Indian, Pakistani foreign secretaries to meet in Islamabad.  Full Article 

Jaitley Speaks

Jaitley Speaks

India needs sustained GDP growth of 9-10 percent - Jaitley.  Full Article 

Obama Interview

Obama Interview

Exclusive - Nemtsov killing sign of worsening climate in Russia: Obama.  Full Article 

Environment Concerns

Environment Concerns

Deforestation could shift monsoons, leaving India high and dry.  Full Article 

Forbes Rich List

Forbes Rich List

Bill Gates tops Forbes rich list, Michael Jordan joins.  Full Article 

New Tour

New Tour

Pop icon Madonna announces dates for 'Rebel Heart' tour.  Full Article 

Lathmar Holi

In Pics: Lathmar Holi

Images of "Lathmar Holi" at Nandgaon in Uttar Pradesh.  Full Coverage 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage